# Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)

> **NCT04510350** · — · COMPLETED · sponsor: **Rennes University Hospital** · enrollment: 90 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Biomarkers analysis

## Key facts

- **NCT ID:** NCT04510350
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-19
- **Primary completion:** 2022-03-02
- **Final completion:** 2022-03-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04510350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04510350, "Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04510350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*